This means that even though TCGA data shows that NETO2, CDK6, OLR1, and TGFBI are underexpressed in HNSCC tissue compared to normal adjacent one, patients who show a low expression of this gene have a better disease outcome with regard to overall survival rate. This evidence concerns the gene OLR1 and head and neck squamous cell carcinoma.